Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$151M |
| 2 |
GE Vernova
GEV
|
+$139M |
| 3 |
Ferrovial SE
FER
|
+$60.1M |
| 4 |
Strategy Inc Common Stock Class A
MSTR
|
+$24M |
| 5 |
Solventum
SOLV
|
+$22.9M |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$184M |
| 2 |
GE Aerospace
GE
|
+$135M |
| 3 |
Apple
AAPL
|
+$117M |
| 4 |
Microsoft
MSFT
|
+$110M |
| 5 |
Meta Platforms (Facebook)
META
|
+$80.5M |
Sector Composition
| 1 | Technology | 33.84% |
| 2 | Healthcare | 12.16% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Communication Services | 9.35% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Sprout Social
SPT
$803M
| $3.49M | ﹤0.01% |
97,841
+1,600
| +2% | +$57.1K |
|
1502
NeoGenomics
NEO
$1.03B
| $3.49M | ﹤0.01% |
251,400
| – | – |
|
1503
Kennametal
KMT
$1.58B
| $3.49M | ﹤0.01% |
148,100
-1,700
| -1% | -$40K |
|
1504
Provident Financial Services
PFS
$2.59B
| $3.48M | ﹤0.01% |
242,729
+101,229
| +72% | +$1.45M |
|
1505
John Wiley & Sons Class A
WLY
$2.19B
| $3.48M | ﹤0.01% |
85,400
-1,100
| -1% | -$44.8K |
|
1506
OFG Bancorp
OFG
$1.95B
| $3.48M | ﹤0.01% |
92,800
| – | – |
|
1507
Reynolds Consumer Products
REYN
$4.84B
| $3.47M | ﹤0.01% |
124,100
| – | – |
|
1508
Arcellx
ACLX
$4.23B
| $3.47M | ﹤0.01% |
62,900
+6,500
| +12% | +$359K |
|
1509
Janus International
JBI
$1.44B
| $3.45M | ﹤0.01% |
272,800
-2,700
| -1% | -$34.1K |
|
1510
Kirby Corp
KEX
$4.8B
| $3.44M | ﹤0.01% |
28,757
-400
| -1% | -$47.9K |
|
1511
Geron
GERN
$810M
| $3.44M | ﹤0.01% |
810,800
+6,500
| +0.8% | +$27.6K |
|
1512
Trustmark
TRMK
$2.43B
| $3.43M | ﹤0.01% |
114,300
| – | – |
|
1513
Acadia Pharmaceuticals
ACAD
$3.98B
| $3.42M | ﹤0.01% |
210,604
| – | – |
|
1514
NovoCure
NVCR
$1.36B
| $3.42M | ﹤0.01% |
199,600
| – | – |
|
1515
QuantumScape
QS
$5.63B
| $3.41M | ﹤0.01% |
694,100
+15,300
| +2% | +$75.3K |
|
1516
Upstart Holdings
UPST
$6.07B
| $3.41M | ﹤0.01% |
144,500
+1,800
| +1% | +$42.5K |
|
1517
Extreme Networks
EXTR
$2.95B
| $3.41M | ﹤0.01% |
253,200
-2,100
| -0.8% | -$28.2K |
|
1518
Helix Energy Solutions
HLX
$914M
| $3.4M | ﹤0.01% |
284,800
+2,500
| +0.9% | +$29.9K |
|
1519
Hanesbrands
HBI
$2.2B
| $3.4M | ﹤0.01% |
689,500
| – | – |
|
1520
Hillman Solutions
HLMN
$1.92B
| $3.4M | ﹤0.01% |
383,900
| – | – |
|
1521
Ardelyx
ARDX
$1.59B
| $3.4M | ﹤0.01% |
458,300
| – | – |
|
1522
Renasant Corp
RNST
$3.68B
| $3.38M | ﹤0.01% |
110,600
| – | – |
|
1523
Remitly
RELY
$3.74B
| $3.37M | ﹤0.01% |
278,100
+3,800
| +1% | +$46.1K |
|
1524
Enova International
ENVA
$2.88B
| $3.37M | ﹤0.01% |
54,100
-4,800
| -8% | -$299K |
|
1525
Rocket Companies
RKT
$44.4B
| $3.37M | ﹤0.01% |
245,700
+8,700
| +4% | +$119K |
|